Yangkui Gu

731 total citations
25 papers, 425 citations indexed

About

Yangkui Gu is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yangkui Gu has authored 25 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yangkui Gu's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Yangkui Gu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Yangkui Gu collaborates with scholars based in China and United States. Yangkui Gu's co-authors include Jinhua Huang, Peihong Wu, Fei Gao, Zilin Huang, Zhimei Huang, Ming Zhao, Chuanxing Li, Tianqi Zhang, Tianqi Zhang and Mengxuan Zuo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Yangkui Gu

25 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangkui Gu China	11	169	154	137	130	53	25	425
Ji Hyeon Joo South Korea	13	93 0.6×	151 1.0×	142 1.0×	125 1.0×	65 1.2×	53	463
Noriko Ii Japan	13	32 0.2×	200 1.3×	185 1.4×	146 1.1×	46 0.9×	40	519
Jeffrey M. Lemons United States	5	62 0.4×	211 1.4×	79 0.6×	408 3.1×	26 0.5×	8	523
Sea-Won Lee South Korea	13	23 0.1×	150 1.0×	129 0.9×	90 0.7×	38 0.7×	37	423
I. Kindts Belgium	9	40 0.2×	305 2.0×	161 1.2×	233 1.8×	71 1.3×	25	581
F. Bonodeau France	8	157 0.9×	129 0.8×	104 0.8×	73 0.6×	31 0.6×	17	356
Khaldoun Kerrou France	11	51 0.3×	111 0.7×	102 0.7×	121 0.9×	21 0.4×	22	424
Sun Mi Moon South Korea	13	99 0.6×	168 1.1×	218 1.6×	275 2.1×	42 0.8×	26	489
Takeshi Ebara Japan	16	30 0.2×	364 2.4×	110 0.8×	162 1.2×	13 0.2×	47	584
Ligang Xing China	13	56 0.3×	284 1.8×	60 0.4×	169 1.3×	19 0.4×	44	594

Countries citing papers authored by Yangkui Gu

Since Specialization

Citations

This map shows the geographic impact of Yangkui Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangkui Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangkui Gu more than expected).

Fields of papers citing papers by Yangkui Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangkui Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangkui Gu. The network helps show where Yangkui Gu may publish in the future.

Co-authorship network of co-authors of Yangkui Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangkui Gu. A scholar is included among the top collaborators of Yangkui Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangkui Gu. Yangkui Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Tianqi, Zhijun Geng, Mengxuan Zuo, et al.. (2023). Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study. Signal Transduction and Targeted Therapy. 8(1). 413–413. 68 indexed citations

Ma, Wenjuan, Jianhong Peng, Ling Zhang, et al.. (2022). Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy. Cell Death and Disease. 13(5). 439–439. 3 indexed citations

Huang, Zhimei, Mengxuan Zuo, Jiayan Ni, et al.. (2020). <p>Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade: A Preliminary Study</p>. Cancer Management and Research. Volume 12. 1373–1385. 5 indexed citations

Huang, Zhimei, Mengxuan Zuo, Yangkui Gu, et al.. (2020). Computed tomography-guided radiofrequency ablation combined with transarterial embolization assisted by a three-dimensional visualization ablation planning system for hepatocellular carcinoma in challenging locations: a preliminary study. Abdominal Radiology. 45(4). 1181–1192. 7 indexed citations

Huang, Zhimei, et al.. (2020). Computed tomography-guided radiofrequency ablation of the retained iodized oil after simultaneous combination with transarterial embolization in small recurrent or residual hepatocellular carcinoma. SHILAP Revista de lepidopterología. 3(1). 49–54. 1 indexed citations

An, Chao, Yiquan Jiang, Zhimei Huang, et al.. (2020). Assessment of Ablative Margin After Microwave Ablation for Hepatocellular Carcinoma Using Deep Learning-Based Deformable Image Registration. Frontiers in Oncology. 10. 573316–573316. 20 indexed citations

Zhang, Yuanping, Yongjin Wang, Yichuan Yuan, et al.. (2020). Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis. World Journal of Surgical Oncology. 18(1). 98–98. 3 indexed citations

Zhang, Tianqi, et al.. (2019). Sequential and Simultaneous 4-Antenna Microwave Ablation in an Ex Vivo Bovine Liver Model. CardioVascular and Interventional Radiology. 42(10). 1466–1474. 7 indexed citations

Han, Xue, Yangkui Gu, Shaolong Li, et al.. (2019). Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma. Translational Cancer Research. 8(5). 1680–1689. 3 indexed citations

10.

Gu, Yangkui, Govindarajan Srimathveeravalli, Li‐Qun Cai, et al.. (2018). Pirfenidone inhibits cryoablation induced local macrophage infiltration along with its associated TGFb1 expression and serum cytokine level in a mouse model. Cryobiology. 82. 106–111. 10 indexed citations

11.

Gu, Yangkui, Zhimei Huang, Haifeng Gu, et al.. (2018). Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?. CardioVascular and Interventional Radiology. 41(6). 912–919. 15 indexed citations

12.

Peng, Jianhong, Wenjuan Ma, Zhongguo Zhou, et al.. (2018). Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery. Journal of Cancer. 9(6). 1067–1077. 6 indexed citations

13.

Zhang, Rongxin, Wenjuan Ma, Yuting Gu, et al.. (2017). Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis. World Journal of Surgical Oncology. 15(1). 138–138. 30 indexed citations

14.

Gu, Haifeng, et al.. (2016). Survival Impact of Ovarian Preservation on Women with Early-Stage Endometrial Cancer. International Journal of Gynecological Cancer. 27(1). 77–84. 35 indexed citations

15.

Li, Cong, Yangkui Gu, Ming Zhao, et al.. (2014). Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer. Cancer Chemotherapy and Pharmacology. 74(5). 1079–1087. 13 indexed citations

16.

Gao, Fei, Yangkui Gu, Jinhua Huang, Ming Zhao, & Peihong Wu. (2012). Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma. Academic Radiology. 19(8). 1035–1040. 18 indexed citations

17.

Gao, Fei, Chuanxing Li, Yangkui Gu, Jinhua Huang, & Peihong Wu. (2012). CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: Effectiveness and safety in 16 patients. European Journal of Radiology. 82(2). e70–e75. 38 indexed citations

18.

Li, Xin, Weijun Fan, Liang Zhang, et al.. (2011). CT‐guided percutaneous microwave ablation of adrenal malignant carcinoma. Cancer. 117(22). 5182–5188. 44 indexed citations

19.

Pan, Changchuan, Ni He, Ming Zhao, et al.. (2010). Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Medical Oncology. 28(4). 1349–1355. 30 indexed citations

20.

Zhang, Liang, Zilin Huang, Peihong Wu, et al.. (2009). Minimally invasive therapy for primary hepatocellular carcinoma with lung metastasis. 15(3). 224–228. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact